title: Why don't we see a greater uptake of computational chemistry approaches by the medicinal chemistry community?
authors.affiliation: Eli Lilly Research Laboratories, Surrey, UK. m.bodkin@lilly.com
authors.forename: Michael James
authors.initials: MJ
authors.lastname: Bodkin
mesh_terms: D002626:Chemistry, Pharmaceutical; D019295:Computational Biology; D015195:Drug Design; D020407:Internet; D008956:Models, Chemical; D012984:Software